TRCT
IH

Tower Research Capital (TRC)’s iHuman IH Stock Holding History

Tower Research Capital (TRC)’s Portfolio IH Stock Details IH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-173
Closed -$1K – 6334
2021
Q3 		$1K Buy
+173
New +$1.29K ﹤0.01% 5487

Other funds holding IH

APA
Arisaig Partners (Asia) Singapore $2.17M AUM 37.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Tower Research Capital (TRC)'s IH Position: Q4 2021 in Review

Tower Research Capital (TRC) sold out of iHuman (IH) in Q4 2021, closing a stake of 173 shares — an estimated $1K sold.

Tower Research Capital (TRC) first reported a position in IH in Q3 2021 and held it in 1 quarter. The position peaked at $1K in Q3 2021. 8 funds tracked by Wall St. Rank hold IH as of Q4 2021.

  • Tower Research Capital (TRC) reported no remaining iHuman position as of Q4 2021 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 173 iHuman shares in Q4 2021, an estimated $1K.
  • Tower Research Capital (TRC) first reported a position in iHuman in Q3 2021 and held it in 1 quarter.
  • Tower Research Capital (TRC)'s iHuman position peaked at $1K in Q3 2021.
  • 8 funds tracked by Wall St. Rank held iHuman as of Q4 2021.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2021, filed 14 Feb 2022.